ALISO VIEJO, Calif., July 1, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a second Contura(tm) MLB short-term breast radiation balloon design.
